|
KR100491282B1
(ko)
|
1996-07-24 |
2005-05-24 |
워너-램버트 캄파니 엘엘씨 |
통증 치료용 이소부틸가바 및 그의 유도체
|
|
AU752444B2
(en)
|
1997-09-18 |
2002-09-19 |
Warner-Lambert Company |
Novel stereoselective processes for the preparation of gabapentin analogues
|
|
DE19751062A1
(de)
*
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
KR20010033153A
(ko)
*
|
1997-12-16 |
2001-04-25 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
4(3)-치환-4(3)-아미노메틸-(티오)피란 또는 -피페리딘유도체(=가바펜틴 동족체), 그의 제법 및 신경 질환 치료용도
|
|
JP2003528148A
(ja)
*
|
2000-03-28 |
2003-09-24 |
デロレンゾ、ロバート・ジェイ |
損傷に際して神経細胞中に形成される新規カルシウム損傷電流の阻害は神経細胞死を抑制する
|
|
EP1343805A4
(en)
|
2000-10-06 |
2005-07-20 |
Xenoport Inc |
COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION
|
|
WO2002032376A2
(en)
|
2000-10-06 |
2002-04-25 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
WO2002100344A2
(en)
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
WO2002100347A2
(en)
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Prodrugs of gaba analogs, compositions and uses thereof
|
|
US7232924B2
(en)
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US6927036B2
(en)
|
2002-02-19 |
2005-08-09 |
Xero Port, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
WO2003099338A2
(en)
|
2002-05-17 |
2003-12-04 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
AU2003297927A1
(en)
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
|
ES2341240T3
(es)
|
2002-12-13 |
2010-06-17 |
Warner-Lambert Company Llc |
Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior.
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
CA2537837A1
(en)
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
|
|
MXPA06002789A
(es)
|
2003-09-12 |
2006-06-14 |
Pfizer |
Combinaciones que comprenden ligandos alfa-2-delta.
|
|
MXPA06003043A
(es)
|
2003-09-17 |
2006-05-31 |
Xenoport Inc |
Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba.
|
|
WO2005037784A2
(en)
|
2003-10-14 |
2005-04-28 |
Xenoport, Inc. |
Crystalline form of gamma-aminobutyric acid analog
|
|
PL1691811T3
(pl)
|
2003-12-11 |
2014-12-31 |
Sunovion Pharmaceuticals Inc |
Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
|
|
EP1811986B1
(en)
|
2004-11-04 |
2014-03-26 |
XenoPort, Inc. |
Gabapentin prodrug sustained release oral dosage forms
|
|
UA94979C2
(uk)
|
2006-12-22 |
2011-06-25 |
Рекордати Айеленд Лимитед |
КОМБІНОВАНА ТЕРАПІЯ ПОРУШЕНЬ НИЖНІХ СЕЧОВИВІДНИХ ШЛЯХІВ ЛІГАНДАМИ α2δ І НПЗП
|
|
CA2697254A1
(en)
*
|
2007-08-23 |
2009-02-26 |
Novartis Ag |
Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
|
|
US7872046B2
(en)
|
2008-01-25 |
2011-01-18 |
Xenoport, Inc. |
Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
|
|
JP5563483B2
(ja)
|
2008-01-25 |
2014-07-30 |
ゼノポート，インコーポレイティド |
アシロキシアルキルカルバメートプロドラッグの合成に使用されるアシロキシアルキルチオカーボネートの鏡像異性的な分解
|
|
WO2009094577A2
(en)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
BRPI0919811B1
(pt)
|
2008-10-08 |
2022-04-19 |
Xgene Pharmaceutical Inc |
Conjugados de gaba e métodos de uso dos mesmos
|
|
WO2010084797A1
(ja)
*
|
2009-01-21 |
2010-07-29 |
第一三共株式会社 |
含ヘテロ原子化合物
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
AU2014209028C1
(en)
|
2013-01-28 |
2019-08-29 |
Hector L. Lopez |
Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
|
|
AU2019271799B2
(en)
|
2018-05-14 |
2023-10-12 |
Xgene Pharmaceutical Inc. |
Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin
|